L18: Tumour Immunology Flashcards

(64 cards)

1
Q

Which mouse study proves that tumours are immunogenic

A

1) inject a carcinogen to a mouse
2) this causes a tumour in that mouse
3) take the live tumour cells and grow it in a lab
4) give the tumour cell to a different mouse and the mouse will also develop a tumour
5) if you irradiate the tumour cell so they cannot divide and vaccinate to another mouse and then give the live tumour cell the mouse will remain tumour free

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the mouse experiment that shows tumours can induce immunological memory

A

1) inject a carcinogen to a mouse
2) mouse develops cancer
3) surgically respect the tumour and collect the tumour cell
4) if you give the tumour cell to a different mouse it will grow a tumour
5) if you give the tumour cell back to the original mouse the mouse will remain tumour free

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In mouse experiments is tumour protection seen in mouse with T cell deficiency

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

If we do not have protection against tumour when there is T cell deficiency what does this indicate

A

That T cell plays a key role in protecting cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the concept of immunosurvelliance

A

The immune system recognises precursors of cancer and destroys the precursor of cancer before they become clinically apparent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the concept of cancer immunoediting

A

Immune system edits the immunogenicity of tumours that may form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the 3 Es of cancer immunoediting

A

Elimination
Equilibrium
Escape

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is elimination

A

Immune mediated destruction of cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is equilibrium

A

Immune system is able to control the outgrowth of tumours but cannot eliminate the tumour cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is escape

A

Tumour mutated variant forms is no longer controlled by the immune system as the cells selected in the equilibrium phase grow out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What MHC complex doeS CD8 T cells detect

A

MHC1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What MHC complex does CD4 T cells detect

A

MHC2 complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Where can MHC complex be found

A

Antigen presenting cells i.e tumour cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does the MHC complex bind to

A

T cell receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When the MHC complex binds to a T cell receptor what happens

A

A signal is delivered to the T cell so it becomes activated = signal 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

After signal 1 one what signal occurs

A

Signal 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does the T cells receive signal 2

A

CD80/CD86 on APC binds to CD28 on T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What can signal 2 be like

A

Positive co-stimulation

Negative co-stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Give an example of positive co-stimulation in signal 2

A

CD80/CD86 binding to CD28 on T cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Give examples of negative co-stimulation

A
  • CD80/CD86 binds to CTLA-4 (on T cell)

- PDL1/2 bins to PD-1 (on T cell)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What does the positive co-stimulation do

A

Activate the T cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What does the negative co-stimulation do to the T cell

A

Suppress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Does CD28 or CTLA-4 binds strongly to CD80/CD86

A

CTLA-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Overall what regulates the activity of T cells

A

Both positive and negative co-stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
If a T cell can recognise a tumour antigen describe how it will occur
1) tumour antigens are released 2) antigen is picked up by dendritic cells 3) dendritic cells drains to lymph nodes 4) dendritic cells present the antigen to T cells 5) if one of the T cells have appropriate receptor for the antigen, the T cell will clonal expand 6) T cells will leave lymph node into the blood to reach tumour site and destroy it
26
What are the tumour associated antigens that can be present for a T cell to recognise
Mutated self proteins generated by dna damage Overexpressed self proteins Lineage specific antigens Abnormal post translational modification of self protein Viral proteins Antigens in the tumour stroma
27
What does the tumour have to be like so we can target it with immunotherapy
Tumour specific : so we don’t destroy health cells Antigen shared amongst different tumour : so we can target many cancer Critical for tumour growth Antigen to which immune system is not tolerant
28
What are the 2 types of immune tolerance
Central tolerance | Peripheral tolerance
29
What is the central tolerance
In the thymus when positive selection (binding to MHC complex) and negative selection (binding to self antigen) occurs
30
What is peripheral tolerance
When any auto reactive T cell that escapes the thymus will be inactive when it interacts with self proteins
31
Why is tolerance important
Cancer develops from our own tumour cels so immune system will be tolerant to it, if a antigen that you are not tolerant to occurs then you can destroy the cell
32
Normally how does a cell process MHC class 1
1) proteins are synthesised in the cytoplasm of the cell 2) proportion of proteins will be Brocken into fragments by proteasome 3) fragments are transported into the ER by TAP transporter so protein is associated to MHC 1 3) MHC 1 becomes exported to the cell surface membrane
33
Additionally when T cells engage with APC what stabilises the interaction
Molecular interactions (adhesion molecules)
34
When would a T cell not be able to detect the tumour cell
``` When there is a interference with: MHC processing Molecular interactions (adhesion molecules) that stabilise the T cell interaction ```
35
What are the mechanism when tumours can escape immune responce
Loss of MHC 1 expression Reduced expression of molecules e.g TAP transporter involved in antigen presentation Loss of co-stimulatory expression e.g CD80/CD86 Loss of adhesion molecules Loss of target antigen Inhibiting T cell infiltration Immunosupression at tumour site
36
What are the 2 ways of inhibiting T cell infiltration to tumour sites
1) endothelins b receptor on the tumour epithelium signals to prevent modulation of ICAM on vascular endotherlium to T cell cannot adhere to the vasculature 2) nitrosylation of chemokines that attract T cells so T cells aren’t attracted
37
What are the ways of immunosuppression at the tumour site
- Tumour cell expresses immunosuppressive cytokines - t reg cells - myeloid derived suppressor cells
38
What is the role of t regulatory cells
Control normal T cells so they are not out of control
39
What can high number of t reg do
Play a role in immune escape
40
What are myeloid derived suppressor cells
A heterogenous cells of myeloid origin that have myeloid progenitor cells, immature macrophages, granulocytes and dendritic cells
41
What happens to myeloid derives suppressor cells during cancer
Expand
42
In cancer what does myeloid derived suppressor cells increase
Immune suppressive factors called arginase 1 and iNOS
43
What does arginase 1 and iNOS metabolise
L-arginine
44
What does loss of l-arginine inhibit
T cell proliferation
45
What are the 3 T cell based therapies for cancer
Non specific T cell stimulation Vaccination Adaptive T cell therapy
46
What does non-specific T cell stimulation involve
The use of immunostimulatory cytokines (toxic) | Blockage of immunologic checkpoints
47
Describe the blockage of immunologic checkpoints
1) administer antagonist antibody 2) antagonist antibody binds to CTLA-4 (negaitve co-stimulatory molecule of T cell function) 3) blocking CTLA-4 means CD28 can bind to CD80/CD86
48
Name an antagonistic antibody used in non specific T cell stimulation to target CTLA-4
Ipilimumab
49
What cancer is ipilimumab used in
Melonoma
50
Name another antagonist antibody that blocks PD1 binding to PDL1/2 on tumour cells for negaitve co-stimulation
Pembrolizumab
51
What cancer is pembrolizumab used in
Melonoma
52
In vaccination what do we give
Irradiated tumour cell Protein antigens Dendritic cell based vaccines
53
What does adaptive T cell therapy involve
1) Injecting T cells from patient or a donor | 2) T cell expands to give lots of T cells that target the tumour antigen
54
In what cancer is adaptive T cell therapy used in
Melonoma
55
How do we generate T cells rapidly
1) A T cell receptor gene is transferred to a T cell | 2) T cell codes for the specific receptor and targets the cancer
56
What are the potential side effects of T cell based therapy
Autoimmunity | Make tumour worse by enhancing angiogenesis
57
What are the other treatments in cancer
Monoclonal antibodies
58
What does antibodies recognise
Antigens on cell surface
59
What are the mono-clonal antibodies immune mediated mechanism
1) antibody mediated lysis | 2) Antibody dependent cellular cytotoxicity
60
How does complement mediated lysis work in monoclonal antibody
1) The antibody binds to target antigen 2) Complement cascade is activated 3) MAC is produced 4) MAC punches a hole in the cell so lysis occurs
61
What is antibody dependent cellular cytotoxicity (ADCC)
1) antibody bind to the antigens 2) NK cells recognise the antibody 3) NK cells kill the tumour cell
62
What are the direct effects of monoclonal antibodies in cancer therapy
1) blocking receptor ligand interaction 2) prevent angiogenesis 3) cytotoxic activity of conjugated antibodies
63
How does monoclonal antibodies prevent angiogenesis
Bind to agonist E.G Vegf
64
What is cytotoxic activity of conjugated antibodies
Antibody delivers toxic molecule to the tumour such as radionuclide